000			02203 a2200625 4500
005			20250518070847.0
264		0	_c20210317
008			202103s 0 0 eng d
022			_a1097-0215
024	7		_a10.1002/ijc.32789 _2doi
040			_aNLM _beng _cNLM
100	1		_aLambertini, Matteo
245	0	0	_aDose-dense adjuvant chemotherapy in HER2-positive early breast cancer patients before and after the introduction of trastuzumab: Exploratory analysis of the GIM2 trial. _h[electronic resource]
260			_bInternational journal of cancer _c07 2020
300			_a160-169 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use
650	0	4	_aBreast Neoplasms _xdrug therapy
650	0	4	_aChemotherapy, Adjuvant
650	0	4	_aClinical Trials, Phase III as Topic
650	0	4	_aCyclophosphamide _xadministration & dosage
650	0	4	_aDisease-Free Survival
650	0	4	_aEpirubicin _xadministration & dosage
650	0	4	_aFemale
650	0	4	_aFluorouracil _xadministration & dosage
650	0	4	_aHumans
650	0	4	_aMiddle Aged
650	0	4	_aMulticenter Studies as Topic
650	0	4	_aPaclitaxel _xadministration & dosage
650	0	4	_aRandomized Controlled Trials as Topic
650	0	4	_aReceptor, ErbB-2 _xmetabolism
650	0	4	_aTrastuzumab _xadministration & dosage
700	1		_aPoggio, Francesca
700	1		_aBruzzone, Marco
700	1		_aConte, Benedetta
700	1		_aBighin, Claudia
700	1		_ade Azambuja, Evandro
700	1		_aGiuliano, Mario
700	1		_aDe Laurentiis, Michele
700	1		_aCognetti, Francesco
700	1		_aFabi, Alessandra
700	1		_aBisagni, Giancarlo
700	1		_aDurando, Antonio
700	1		_aTurletti, Anna
700	1		_aUrracci, Ylenia
700	1		_aGarrone, Ornella
700	1		_aPuglisi, Fabio
700	1		_aMontemurro, Filippo
700	1		_aCeppi, Marcello
700	1		_aDel Mastro, Lucia
773	0		_tInternational journal of cancer _gvol. 147 _gno. 1 _gp. 160-169
856	4	0	_uhttps://doi.org/10.1002/ijc.32789 _zAvailable from publisher's website
999			_c30310006 _d30310006